Suven Pharmaceuticals Ltd Quarterly Results

Gross Sales

549.31

840.42

307.15

257.72

488.08

Excise Duty

0

0

0

0

0

Net Sales

549.31

840.42

307.15

257.72

488.08

Other Operating Income

0

0

0

0

0

Other Income

14.17

12.05

15.71

14.12

19.41

Total Income

563.48

852.47

322.86

271.84

507.49

Total Expenditure

445.4

626.98

189.45

153.71

362.98

PBIDT

118.08

225.49

133.41

118.13

144.51

Interest

10.18

10.45

3.33

1.67

10.2

PBDT

107.9

215.04

130.08

116.46

134.31

Depreciation

45.14

54.17

20.35

16.96

31.28

Minority Interest Before NP

0

0

0

0

0

Tax

18.18

31.9

41.6

27.91

26.76

Deferred Tax

-1.82

11.82

-15.16

-10.39

0.9

Reported Profit After Tax

46.4

117.15

83.29

81.98

75.37

Minority Interest After NP

-2.48

-3.28

0.41

-0.23

0

Net Profit after Minority Interest

48.88

120.43

82.88

82.21

75.37

Extra-ordinary Items

-5.75

-11.49

0

0

0

Adjusted Profit After Extra-ordinary item

54.63

131.92

82.88

82.21

75.37

EPS (Unit Curr.)

1.28

3.16

3.26

3.23

1.98

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

38.26

25.46

25.46

25.46

25.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.49

26.83

43.43

45.83

29.6

PBDTM(%)

19.64

25.58

42.35

45.18

27.51

PATM(%)

8.44

13.93

27.11

31.8

15.44